Get started
Author

Divakar Selvaraj

Observed names: Divakar S., Divakar Selva, S. Divakar, Selva Divakar, Selvaraj Divakar
ORCID: 0000-0002-6434-6583
Observed ORCID: 0000-0002-6434-6583
OpenAlex ID: A5036761722
The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease
2022 · Amritha Chakkittukandiyil, Deepak Vasudevan Sajini, et al. · Neurochemistry International · 75
Synergistic and enhanced anticancer effect of a facile surface modified non-cytotoxic silver nanoparticle conjugated with gemcitabine in metastatic breast cancer cells
2019 · Arjunan Karuppaiah, Karthik Siram, et al. · Materials Today Communications · 45
Design, synthesis and biological evaluation of 2-(4-phenylthiazol-2-yl) isoindoline-1,3-dione derivatives as anti-prostate cancer agents
2017 · K. Saravanan, R. Elancheran, et al. · Bioorganic & Medicinal Chemistry Letters · 37
Quillaja saponin: A prospective emulsifier for the preparation of solid lipid nanoparticles
2016 · Siram Karthik, Chellan Vijaya Raghavan, et al. · Colloids and Surfaces B Biointerfaces · 37
Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking,in-vitroand molecular dynamics study
2020 · Divakar Selvaraj, Santhoshkumar Muthu, et al. · Journal of Biomolecular Structure and Dynamics · 36
Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats
2021 · Arjunan Karuppaiah, Dinesh Babu, et al. · European Journal of Pharmaceutical Sciences · 31
Design and development of oxobenzimidazoles as novel androgen receptor antagonists
2016 · R. Elancheran, K. Saravanan, et al. · Medicinal Chemistry Research · 29
Rational Design, Synthesis, and In Vitro Neuroprotective Evaluation of Novel Glitazones for PGC-1α Activation via PPAR-γ: a New Therapeutic Strategy for Neurodegenerative Disorders
2019 · Antony Justin, Subhankar Mandal, et al. · Neurotoxicity Research · 28
Design, Synthesis and Biological Evaluation of Novel 1, 3- thiazolidine-2, 4-diones as Anti-prostate Cancer Agents
2018 · Ramakrishnan Elancheran, Kuppusamy Saravanan, et al. · Anti-Cancer Agents in Medicinal Chemistry · 28
Oral delivery of solid lipid nanoparticles surface decorated with hyaluronic acid and bovine serum albumin: A novel approach to treat colon cancer through active targeting
2024 · Syed Suhaib Ahmed, Mohd Zubair Baba, et al. · International Journal of Biological Macromolecules · 22
Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT1 and not AT2 receptor
2018 · A. Justin, S. Divakar, et al. · Biomedicine & Pharmacotherapy · 21
Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases
2024 · Emdormi Rymbai, Deepa Sugumar, et al. · Cell Biochemistry and Function · 18
The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson's disease models
2023 · Emdormi Rymbai, Deepa Sugumar, et al. · Life Sciences · 18
Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma
2022 · Anusha Shreenidhi Bhat, Ningthoujam Anirudh Singh, et al. · Reproductive Sciences · 17
Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway
2017 · S. Divakar, K. Saravanan, et al. · Chemico-Biological Interactions · 16
An in-depth review of PPARγ modulators as anti-diabetes therapeutics
2025 · Aryan Jangra, Basuvan Babu, et al. · Drug Metabolism Reviews · 11
Acetylcholinesterase Inhibitors from Carbamate and Benzo-fused Heterocyclic Scaffolds: Promising Therapeutics for Alzheimer’s Disease
2025 · Amarjith Thiyyar Kandy, Raghul Venkatesan, et al. · Medicinal Chemistry Research · 11
Ligand Based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies to Design Novel Pancreatic Lipase Inhibitors
2017 · Maida Engels, Se Balaji B, et al. · International Journal of Pharmacy and Pharmaceutical Sciences · 11
PDF
In vitro Screening of the Leaf Extracts from Gardenia ternifolia (Forest Gardenia) for their Anticancer Activity
2016 · Damien Tshibangu, Selvaraj Divakar, et al. · Journal of Complementary and Alternative Medical Research · 11
PDF
An integrated network pharmacology and molecular modelling study of phytoconstituents targeting Alzheimer's disease
2023 · Saumya Khanna, Divakar Selvaraj, et al. · Medicine in Omics · 10
A Perspective on Therapeutic Applications and Strategies to Mitigate Toxicity of Metallic Nanoparticles
2023 · Arjunan Karuppaiah, Divakar Selvaraj, et al. · Current Pharmaceutical Design · 10
G-Lymphatic, Vascular and Immune Pathways for Aβ Clearance Cascade and Therapeutic Targets For Alzheimer’s Disease
2020 · Saurav Chakraborty, Jyothsna ThimmaReddygari, et al. · Combinatorial Chemistry & High Throughput Screening · 10
Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2/ARE pathway in Parkinson's disease
2024 · Amritha Chakkittukandiyil, Deepak Vasudevan Sajini, et al. · Toxicology and Applied Pharmacology · 9
Side effects based network construction and drug repositioning of ropinirole as a potential molecule for Alzheimer’s disease: an in-silico , in-vitro , and in-vivo study
2023 · Amritha Chakkittukandiyil, Saurav Chakraborty, et al. · Journal of Biomolecular Structure and Dynamics · 8
3D-QSAR Studies on Plasmodium falciparam Proteins: A Mini-Review
2015 · Selva Divakar, Sivaram Hariharan · Combinatorial Chemistry & High Throughput Screening · 8
Works count: 66
Citation count: 641
H-index: 15
I10-index: 22
Year
Topic
Type